Clinical predictors of intussusception identified

Article

Investigators developed two "decision trees" to stratify the risk of children being evaluated for intussusception.

Investigators developed 2 "decision trees" to stratify the risk of children being evaluated for intussusception. The prediction models were based on identification of clinical predictors of intussusception along with, in 1 model, an abdominal x-ray or ultrasound.

Investigators collected data for 310 enrolled children from 1 month to 6 years of age (median, 21.1 months) who visited an urban, tertiary care pediatric emergency department with signs and symptoms of possible intussusception, which was diagnosed in 38 (12.3%) of them.

Eighty-three percent of the children had abdominal pain, 56% had vomiting, and 36% were reported to be lethargic; 77% of the children had 2 or more of these features. After being assessed, all the children had abdominal imaging, either an abdominal x-ray or an ultrasound. Of patients with intussusception, 23% had a positive x-ray, and 54% had a possible positive x-ray.

For the low-risk decision tree without imaging (sensitivity, 89%), investigators included 3 variables: age, gender, and lethargy, indicating that children who are either 5 months old or younger or children who are older than 5 months, female, and without lethargy are at low risk of intussusception.

For the low-risk decision tree with imaging (sensitivity, 97%), patients with a negative plain x-ray who are 5 months old or younger are at low risk of intussusception. Patients with a negative x-ray who are older than 5 months and have diarrhea but don't have bilious vomiting also are at low risk. (Weihmiller SN, et al. Pediatrics. 2011;127[2]:e296-e303).

Commentary

I hope that this predictive model holds up to further study. If it works, it will make life easier for doctors considering intussusception in the emergency department and for their patients. -Michael Burke, MD

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
David Brousseau, MD, highlights impact of timely opioid dosing in pediatric sickle cell pain
Richard Bermudes, MD, on screen-related addictions and youth mental health
© 2025 MJH Life Sciences

All rights reserved.